Dr. Eid Mansour has been appointed as the new general manager of Gilead Sciences in Saudi Arabia

In a noteworthy announcement, Gilead Sciences, a prominent biopharmaceutical company based in the Kingdom of Saudi Arabia, is pleased to introduce Dr. Eid Mansour as the newly appointed General Manager (GM) for Saudi Arabia. Dr. Mansour, a seasoned professional with an impressive track record, will spearhead the company's operations and drive its growth within the Kingdom.

As a Medical Doctor, Dr. Mansour brings a wealth of experience, boasting eighteen years in the pharmaceutical industry. His career has been marked by strategic leadership roles at both the Global and European levels. Dr. Mansour has successfully led multicultural teams, established new capabilities in terms of teams and departments, and achieved business success in multiple countries worldwide. Dr. Mansour's history with Gilead is extensive, having previously led the HIV business, played a pivotal role in developing the Market Access Capability Department, and overseen the digital transformation initiatives for Gilead in the Middle East Region.

Vitor Papao, General Manager (GM), Gilead Sciences Middle East, welcomed Eid saying, “Eid’s appointment comes at a pivotal time as Gilead continues to solidify its presence and drive the pursuit of transformative science to tackle life-threatening diseases in the Kingdom and wider region. We are excited for a new tenure of leadership in Saudi Arabia which we are confident will elevate Gilead’s operations to their highest potential with the aim of continuing to answer the needs of the patients we serve.”

In response to his new role, Dr. Eid Mansour stated, “I am thrilled to take on this new position at Gilead Saudi Arabia and work with the team to contribute to the 2030 vision and the National Transformation Plan in the Kingdom. I look forward to reinforcing our commitment to serve the patients with our innovative treatment solutions in the field of virology, oncology and fungal infections. My dedication to ensuring operational excellence and strengthening Gilead’s standing as a frontrunner in the healthcare sector is unwavering, and I am excited about the amazing journey I am embarking upon.”

The appointment of Dr. Mansour is seen as a strategic move, leveraging his expertise and proven leadership in managing complex operations across diverse markets. This move is expected to reinforce Gilead's commitment to knowledge sharing and technology transfer across various therapeutic areas, further solidifying the company's position in the region.